# Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal

> **NCT00896012** · PHASE4 · COMPLETED · sponsor: **University at Buffalo** · enrollment: 58 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **PROCEDURE:** Kidney Biopsy
- **DRUG:** Rapamune (sirolimus/rapamycin)
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00896012
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-11-11
- **Final completion:** 2011-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896012, "Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00896012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*